NEW ORLEANS – From Tulane University:
Could some of those who died from COVID-19 and other infectious diseases have been stored using a diagnosis that predicts the severity of their case and provides faster treatment?
A team of engineers and doctors at Tulane University hopes to respond to this with the progression of a new generation designed to stumble upon the severe headaches of COVID-19, such as thrombosis, a condition in which blood clots block veins and arteries.
“Many patients who died from COVID-19 and other infectious diseases developed severe thrombotic headaches some time after the onset of symptoms of the disease,” said Damir Khismatullin, PhD, associate professor of biomedical engineering in Tulane’s School of Science and Engineering. “It is possible that their lives are only stored through an expected diagnosis of the severity of the disease and triggering treatment. However, tests that await the severity of infectious diseases are not yet available. “
Khismatullin and his team recently won a nearly $600,000 Trailblazer Award from the National Institute of Biomedical Imaging and Bioengineering to adopt studies leading to such tests. or without initial data.
The co-investigators of Khismatullin’s team from Tulane University School of Medicine, Dr. Dahlene Fusco, infectious disease specialist, associate professor, and Dr. Arnaud Drouin, clinical pathologist, adjunct assistant professor.
The goal is to scale up a diagnostic test that uses a drop of blood drawn from a finger prick, a test that can be done in the hospital, in a clinic, or at home.
Many other people have died from COVID-19 due to the immediate progression of headaches caused by the so-called immune-induced cytokine typhoon, which the body too temporarily releases too many inflammatory proteins called cytokines into the bloodstream. Symptoms come with high fever, severe fatigue, and, infrequently, organ failure.
A cytokine typhoon can cause blood to clot in the body’s blood vessels. For COVID-19 patients, this can lead to headaches that contribute to breathing difficulties and ultimately lead to the death of the patient.
Developed through Robly™